Literature DB >> 31627904

[Factors limiting outpatient management in breast surgery].

Philippe Rauch1, Julia Salleron2, Julie Buhler3, Léa Leufflen3, Frédéric Marchal4.   

Abstract

INTRODUCTION: Breast cancer surgery associates interventions of short duration and low morbidity, mostly accessible for outpatient management.
METHODS: We performed a descriptive, retrospective, monocentric study involving 1735 patients operated between 1st of July 2015 and the 31st of December 2017 of a mammary or axillary lymph node procedure. A comparative study was carried out, involving 2 groups of patients treated either on an outpatient or conventional hospitalization mode, in order to find the main medico-social factors that could constitute barriers to this ambulatory modality.
RESULTS: In total, 992 patients were treated in outpatient surgery and 743 in conventional surgery. The mean age of the ambulatory group was 56.9 years (±11.2), versus 65.9 years (±13.5) in the conventional hospitalization group. Thirteen stays (1.3%) had to be converted into conventional hospitalization. The main factors limiting outpatient management are age≥70 years, BMI≥25, isolation of the patient, total mastectomy, and drainage.
CONCLUSION: Because of social, medical or psychological constraints, the rate of outpatient breast surgery remains in our practice, stable in recent years at 56%. Some ways of improvement can be envisaged, but it is likely that this rate will only increase in a very gradual manner in the years to come.
Copyright © 2019 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Ambulatory surgery; Breast Cancer surgery; Cancer du sein; Chirurgie ambulatoire; Day Surgery

Year:  2019        PMID: 31627904     DOI: 10.1016/j.bulcan.2019.08.018

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  1 in total

1.  The Quest for Outpatient Mastectomy in COVID-19 Era: Barriers and Facilitators.

Authors:  L J van Zeelst; R Derksen; C H W Wijers; J Hegeman; R Berry; J H W de Wilt; L J A Strobbe
Journal:  Breast J       Date:  2022-06-01       Impact factor: 2.269

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.